Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-106549
Filing Date
2025-08-11
Accepted
2025-08-11 16:10:27
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20250630.htm   iXBRL 10-Q 3303886
2 EX-10.1 fgen-ex10_1.htm EX-10.1 40068
3 EX-31.1 fgen-ex31_1.htm EX-31.1 10221
4 EX-31.2 fgen-ex31_2.htm EX-31.2 10215
5 EX-32.1 fgen-ex32_1.htm EX-32.1 10202
  Complete submission text file 0000950170-25-106549.txt   11638850

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250630.xsd EX-101.SCH 1845032
73 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250630_htm.xml XML 1872704
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 251202088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)